Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
Joint Authors
Zhang, Yue-Hua
Lu, Yuquan
Lu, Hong
Zhang, Meng-Wei
Zhou, Yue-Min
Li, Xiang-Lei
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-05-15
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Background/Aim.
Few studies have reported the prognostic value of pretreatment hemoglobin levels in patients with lung adenocarcinoma (LA).
In the present study, we retrospectively reviewed 306 LA patients for their prognosis associated with the pretreatment hemoglobin levels.
Methods.
Person-years and case fatality rate (CFR) were calculated from May 2010 to June 2017.
Hazard ratio (HR) and 95% confidence intervals (CIs) were estimated using the Cox proportional hazards regression analysis.
Survival curves were generated using the Kaplan–Meier analysis.
Results.
Patients with low pretreatment hemoglobin (LPHb) levels had a higher CFR than did patients with normal pretreatment hemoglobin (NPHb) levels (HR = 1.48, 95% CI = 1.06–2.08, and P=0.023).
Overall survival of NPHb patients was significantly higher than that of LPHb patients (P<0.05).
Conclusion.
Low pretreatment hemoglobin level was demonstrated to be an independent biomarker for poor prognosis in patients with LA.
American Psychological Association (APA)
Zhang, Yue-Hua& Lu, Yuquan& Lu, Hong& Zhang, Meng-Wei& Zhou, Yue-Min& Li, Xiang-Lei. 2018. Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma. Canadian Respiratory Journal،Vol. 2018, no. 2018, pp.1-6.
https://search.emarefa.net/detail/BIM-1151835
Modern Language Association (MLA)
Zhang, Yue-Hua…[et al.]. Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma. Canadian Respiratory Journal No. 2018 (2018), pp.1-6.
https://search.emarefa.net/detail/BIM-1151835
American Medical Association (AMA)
Zhang, Yue-Hua& Lu, Yuquan& Lu, Hong& Zhang, Meng-Wei& Zhou, Yue-Min& Li, Xiang-Lei. Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma. Canadian Respiratory Journal. 2018. Vol. 2018, no. 2018, pp.1-6.
https://search.emarefa.net/detail/BIM-1151835
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1151835
